about
Tumor immunotargeting using innovative radionuclidesNon-invasive in vivo imaging of near infrared-labeled transferrin in breast cancer cells and tumors using fluorescence lifetime FRET.Antitumor immunity induced after α irradiationDiscovery of hapten-specific scFv from a phage display library and applications for HER2-positive tumor imagingTumor imaging and targeting potential of an Hsp70-derived 14-mer peptide.Impact of α-targeted radiation therapy on gene expression in a pre-clinical model for disseminated peritoneal disease when combined with paclitaxel.Radioimmunotherapy with α-particle-emitting radionuclides.Novel DNA Polymer for Amplification Pretargeting.Cell Killing Mechanisms and Impact on Gene Expression by Gemcitabine and 212Pb-Trastuzumab Treatment in a Disseminated i.p. Tumor Model.Single-Dose Anti-CD138 Radioimmunotherapy: Bismuth-213 is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical ModelCarcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting.Fractionated intravesical radioimmunotherapy with (213)Bi-anti-EGFR-MAb is effective without toxic side-effects in a nude mouse model of advanced human bladder carcinoma.Nanovectorized radiotherapy: a new strategy to induce anti-tumor immunity.Radiolabeling strategies for tumor-targeting proteinaceous drugs.New insights into the pretargeting approach to image and treat tumours.The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis.Protein based therapeutic delivery agents: Contemporary developments and challenges.Radioimmunotherapy for delivery of cytotoxic radioisotopes: current status and challenges.Current status and future directions of cancer immunotherapy.In vivo demonstration of an active tumor pretargeting approach with peptide nucleic acid bioconjugates as complementary system.Radioimmunotherapy of B-Cell Non-Hodgkin's Lymphoma.
P2860
Q28083230-D79238FE-7185-4709-A975-AC38E58985EDQ30416226-BA1AF538-7F2C-4EDA-ADD0-954DC3254900Q33891246-4CF3919B-3180-4300-836C-F03DEDAD2177Q33921086-ADF18A58-7176-4227-9D8E-F075EB5A5236Q34104760-365401B9-F0ED-4137-B89A-58F536AB8FA9Q34277296-3640E0A0-BD8B-449A-A938-DAF3CA8C2588Q34419562-1C586377-D080-4337-8D2E-A2BCE01B6828Q36059787-4C2845E4-DBA9-4335-A68C-D7C1A5046B99Q36088727-1CB14507-3240-40DF-8E5E-BBB9FC78ADF9Q36245624-9C9418BE-5662-424C-837E-AED798CB77E6Q36671897-1E64A575-68BD-4D07-9C0A-15126A95B67BQ36838996-644990BC-E2F8-4D24-B128-51669C07B52DQ38054112-BC330B41-45F3-48BC-8240-9887A51C8CA7Q38189541-5B607C1B-B714-4496-AA66-7BE7B79B95CCQ38976879-4E1001C4-B0E2-47FC-9F3A-C268F0D7BB48Q39014347-AE04615A-1095-40BC-B112-BB25ECBD94A1Q39273739-157135FB-A263-4FB3-B3C3-A17B6A7D772CQ50149863-1870D464-90F8-441B-9833-2CB6E7FC50D2Q55070491-BF1830A0-A621-4768-A5BC-60FF83C08D7AQ55093431-5A138227-2D05-4BC3-926B-666D838F63F1Q55689230-865A32AF-FB19-4466-8FFE-58EA418B5F10
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Radiolabeled antibodies for cancer imaging and therapy.
@en
type
label
Radiolabeled antibodies for cancer imaging and therapy.
@en
prefLabel
Radiolabeled antibodies for cancer imaging and therapy.
@en
P2093
P50
P1476
Radiolabeled antibodies for cancer imaging and therapy.
@en
P2093
François Davodeau
Jacques Barbet
Jean-François Chatal
Jean-François Gestin
Manuel Bardiès
Michel Chérel
P304
P356
10.1007/978-1-61779-974-7_38
P407
P577
2012-01-01T00:00:00Z